Skip to main content
. 2017 Jul 22;40(10):855–869. doi: 10.1007/s40264-017-0572-8

Fig. 5.

Fig. 5

Types of Pharmacovigilance Risk Assessment Committee recommendations for signals. DHPC direct healthcare professional communication, PASS post-authorisation safety study, PI product information, PSUR periodic update safety report, RMP risk management plan, USR urgent safety restriction